ID

18290

Description

Safety and Efficacy Study of Doxycycline in Combination With Interferon-B-1a to Treat Multiple Sclerosis; ODM derived from: https://clinicaltrials.gov/show/NCT00246324

Link

https://clinicaltrials.gov/show/NCT00246324

Keywords

Versions (1)
  1. 10/28/16 10/28/16 -
Uploaded on

October 28, 2016

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Multiple Sclerosis NCT00246324

English

Eligibility Multiple Sclerosis NCT00246324

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
age 18-55
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
relapsing-remitting multiple sclerosis (rrms)
Description

Multiple Sclerosis, Relapsing-Remitting

Data type

boolean

Alias
UMLS CUI [1]
C0751967
avonex therapy for 6 months prior continuous
Description

Avonex

Data type

boolean

Alias
UMLS CUI [1]
C0594372
annualized relapse rate >2 during avonex therapy
Description

Avonex | Relapse Rate Annual

Data type

boolean

Alias
UMLS CUI [1]
C0594372
UMLS CUI [2,1]
C0035020
UMLS CUI [2,2]
C1521828
UMLS CUI [2,3]
C0332181
most recent relapse within 60 days of baseline
Description

Relapse Most Recent

Data type

boolean

Alias
UMLS CUI [1,1]
C0035020
UMLS CUI [1,2]
C1513491
entry expanded disability status scale (edss) 1.5-4.5
Description

EDSS

Data type

boolean

Alias
UMLS CUI [1]
C0451246
one or more gadolinium (gd+) mri lesions on a baseline mri
Description

Gadolinium-Enhancing Lesion | Magnetic Resonance Imaging

Data type

boolean

Alias
UMLS CUI [1]
C1333400
UMLS CUI [2]
C0024485
no history of immune modulator or immunosuppressant therapy used in combination with avonex (other then gsc administer for clinical relapses)
Description

Immunomodulation | Therapeutic immunosuppression | Avonex | Glucocorticoids Relapse Clinical

Data type

boolean

Alias
UMLS CUI [1]
C1963758
UMLS CUI [2]
C0021079
UMLS CUI [3]
C0594372
UMLS CUI [4,1]
C0017710
UMLS CUI [4,2]
C0035020
UMLS CUI [4,3]
C0205210
not participating in any other study of ms therapeutics
Description

Study Subject Participation Status | Therapeutic procedure Multiple Sclerosis

Data type

boolean

Alias
UMLS CUI [1]
C2348568
UMLS CUI [2,1]
C0087111
UMLS CUI [2,2]
C0026769
serum neutralizing antibodies (nabs) titer to avonex <20
Description

Avonex | Serum Neutralizing Antibodies Titer

Data type

boolean

Alias
UMLS CUI [1]
C0594372
UMLS CUI [2,1]
C0229671
UMLS CUI [2,2]
C0475463
UMLS CUI [2,3]
C0475208
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
medical or psychiatric conditions that will affect patients ability to provide informed consent
Description

Medical condition Affecting Informed Consent | Mental condition Affecting Informed Consent

Data type

boolean

Alias
UMLS CUI [1,1]
C3843040
UMLS CUI [1,2]
C0392760
UMLS CUI [1,3]
C0021430
UMLS CUI [2,1]
C3840291
UMLS CUI [2,2]
C0392760
UMLS CUI [2,3]
C0021430
inability to undergo mri
Description

Magnetic Resonance Imaging Receive Unable

Data type

boolean

Alias
UMLS CUI [1,1]
C0024485
UMLS CUI [1,2]
C1514756
UMLS CUI [1,3]
C1299582
clinically serious medical conditions or significantly abnormal labs
Description

Medical condition Serious Clinical | Laboratory Results Abnormal Significant

Data type

boolean

Alias
UMLS CUI [1,1]
C3843040
UMLS CUI [1,2]
C0205404
UMLS CUI [1,3]
C0205210
UMLS CUI [2,1]
C1254595
UMLS CUI [2,2]
C0205161
UMLS CUI [2,3]
C0750502
no use of these medications or procedures within six months prior to study:
Description

Pharmaceutical Preparations Use | Therapeutic procedure Use

Data type

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C1524063
UMLS CUI [2,1]
C0087111
UMLS CUI [2,2]
C1524063
*monoclonal antibodies,total lymphoid radiation,systemic steroids,cytotoxic or immunosuppressive medications such as mitoxantrone or cyclophosphamide or any other investigational drugs
Description

Monoclonal Antibodies | Total Lymphatic Radiation Therapy | systemic steroids | Cytotoxic agent | Immunosuppressive Agents | Mitoxantrone | Cyclophosphamide | Investigational New Drugs

Data type

boolean

Alias
UMLS CUI [1]
C0003250
UMLS CUI [2,1]
C0086572
UMLS CUI [2,2]
C0439810
UMLS CUI [3]
C2825233
UMLS CUI [4]
C0304497
UMLS CUI [5]
C0021081
UMLS CUI [6]
C0026259
UMLS CUI [7]
C0010583
UMLS CUI [8]
C0013230
interferon neutralizing antibody titers >20
Description

Interferon Neutralizing Antibodies Titer

Data type

boolean

Alias
UMLS CUI [1,1]
C0021747
UMLS CUI [1,2]
C0475463
UMLS CUI [1,3]
C0475208
no breast feeding or pregnant
Description

Breast Feeding | Pregnancy

Data type

boolean

Alias
UMLS CUI [1]
C0006147
UMLS CUI [2]
C0032961
no patients with any systemic illness,psychiatric condition or other disorder that would concern safety of patient to complete procedures of protocol
Description

Systemic disease Affecting patient safety | Systemic disease Affecting Protocol Compliance | Mental condition Affecting patient safety | Mental condition Affecting Protocol Compliance | Disease Affecting patient safety | Disease Affecting Protocol Compliance

Data type

boolean

Alias
UMLS CUI [1,1]
C0442893
UMLS CUI [1,2]
C0392760
UMLS CUI [1,3]
C1113679
UMLS CUI [2,1]
C0442893
UMLS CUI [2,2]
C0392760
UMLS CUI [2,3]
C0525058
UMLS CUI [3,1]
C3840291
UMLS CUI [3,2]
C0392760
UMLS CUI [3,3]
C1113679
UMLS CUI [4,1]
C3840291
UMLS CUI [4,2]
C0392760
UMLS CUI [4,3]
C0525058
UMLS CUI [5,1]
C0012634
UMLS CUI [5,2]
C0392760
UMLS CUI [5,3]
C1113679
UMLS CUI [6,1]
C0012634
UMLS CUI [6,2]
C0392760
UMLS CUI [6,3]
C0525058
abnormal blood test
Description

Blood test abnormal

Data type

boolean

Alias
UMLS CUI [1]
C0854146
clinically significant abnormality on chest x-ray (cxr)
Description

Chest X-ray abnormal Clinical Significance

Data type

boolean

Alias
UMLS CUI [1,1]
C0436503
UMLS CUI [1,2]
C2826293
Back to the top of the page

Similar models

Eligibility Multiple Sclerosis NCT00246324

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
age 18-55
boolean
C0001779 (UMLS CUI [1])
Multiple Sclerosis, Relapsing-Remitting
Item
relapsing-remitting multiple sclerosis (rrms)
boolean
C0751967 (UMLS CUI [1])
Avonex
Item
avonex therapy for 6 months prior continuous
boolean
C0594372 (UMLS CUI [1])
Avonex | Relapse Rate Annual
Item
annualized relapse rate >2 during avonex therapy
boolean
C0594372 (UMLS CUI [1])
C0035020 (UMLS CUI [2,1])
C1521828 (UMLS CUI [2,2])
C0332181 (UMLS CUI [2,3])
Relapse Most Recent
Item
most recent relapse within 60 days of baseline
boolean
C0035020 (UMLS CUI [1,1])
C1513491 (UMLS CUI [1,2])
EDSS
Item
entry expanded disability status scale (edss) 1.5-4.5
boolean
C0451246 (UMLS CUI [1])
Gadolinium-Enhancing Lesion | Magnetic Resonance Imaging
Item
one or more gadolinium (gd+) mri lesions on a baseline mri
boolean
C1333400 (UMLS CUI [1])
C0024485 (UMLS CUI [2])
Immunomodulation | Therapeutic immunosuppression | Avonex | Glucocorticoids Relapse Clinical
Item
no history of immune modulator or immunosuppressant therapy used in combination with avonex (other then gsc administer for clinical relapses)
boolean
C1963758 (UMLS CUI [1])
C0021079 (UMLS CUI [2])
C0594372 (UMLS CUI [3])
C0017710 (UMLS CUI [4,1])
C0035020 (UMLS CUI [4,2])
C0205210 (UMLS CUI [4,3])
Study Subject Participation Status | Therapeutic procedure Multiple Sclerosis
Item
not participating in any other study of ms therapeutics
boolean
C2348568 (UMLS CUI [1])
C0087111 (UMLS CUI [2,1])
C0026769 (UMLS CUI [2,2])
Avonex | Serum Neutralizing Antibodies Titer
Item
serum neutralizing antibodies (nabs) titer to avonex <20
boolean
C0594372 (UMLS CUI [1])
C0229671 (UMLS CUI [2,1])
C0475463 (UMLS CUI [2,2])
C0475208 (UMLS CUI [2,3])
Item Group
C0680251 (UMLS CUI)
Medical condition Affecting Informed Consent | Mental condition Affecting Informed Consent
Item
medical or psychiatric conditions that will affect patients ability to provide informed consent
boolean
C3843040 (UMLS CUI [1,1])
C0392760 (UMLS CUI [1,2])
C0021430 (UMLS CUI [1,3])
C3840291 (UMLS CUI [2,1])
C0392760 (UMLS CUI [2,2])
C0021430 (UMLS CUI [2,3])
Magnetic Resonance Imaging Receive Unable
Item
inability to undergo mri
boolean
C0024485 (UMLS CUI [1,1])
C1514756 (UMLS CUI [1,2])
C1299582 (UMLS CUI [1,3])
Medical condition Serious Clinical | Laboratory Results Abnormal Significant
Item
clinically serious medical conditions or significantly abnormal labs
boolean
C3843040 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C0205210 (UMLS CUI [1,3])
C1254595 (UMLS CUI [2,1])
C0205161 (UMLS CUI [2,2])
C0750502 (UMLS CUI [2,3])
Pharmaceutical Preparations Use | Therapeutic procedure Use
Item
no use of these medications or procedures within six months prior to study:
boolean
C0013227 (UMLS CUI [1,1])
C1524063 (UMLS CUI [1,2])
C0087111 (UMLS CUI [2,1])
C1524063 (UMLS CUI [2,2])
Monoclonal Antibodies | Total Lymphatic Radiation Therapy | systemic steroids | Cytotoxic agent | Immunosuppressive Agents | Mitoxantrone | Cyclophosphamide | Investigational New Drugs
Item
*monoclonal antibodies,total lymphoid radiation,systemic steroids,cytotoxic or immunosuppressive medications such as mitoxantrone or cyclophosphamide or any other investigational drugs
boolean
C0003250 (UMLS CUI [1])
C0086572 (UMLS CUI [2,1])
C0439810 (UMLS CUI [2,2])
C2825233 (UMLS CUI [3])
C0304497 (UMLS CUI [4])
C0021081 (UMLS CUI [5])
C0026259 (UMLS CUI [6])
C0010583 (UMLS CUI [7])
C0013230 (UMLS CUI [8])
Interferon Neutralizing Antibodies Titer
Item
interferon neutralizing antibody titers >20
boolean
C0021747 (UMLS CUI [1,1])
C0475463 (UMLS CUI [1,2])
C0475208 (UMLS CUI [1,3])
Breast Feeding | Pregnancy
Item
no breast feeding or pregnant
boolean
C0006147 (UMLS CUI [1])
C0032961 (UMLS CUI [2])
Systemic disease Affecting patient safety | Systemic disease Affecting Protocol Compliance | Mental condition Affecting patient safety | Mental condition Affecting Protocol Compliance | Disease Affecting patient safety | Disease Affecting Protocol Compliance
Item
no patients with any systemic illness,psychiatric condition or other disorder that would concern safety of patient to complete procedures of protocol
boolean
C0442893 (UMLS CUI [1,1])
C0392760 (UMLS CUI [1,2])
C1113679 (UMLS CUI [1,3])
C0442893 (UMLS CUI [2,1])
C0392760 (UMLS CUI [2,2])
C0525058 (UMLS CUI [2,3])
C3840291 (UMLS CUI [3,1])
C0392760 (UMLS CUI [3,2])
C1113679 (UMLS CUI [3,3])
C3840291 (UMLS CUI [4,1])
C0392760 (UMLS CUI [4,2])
C0525058 (UMLS CUI [4,3])
C0012634 (UMLS CUI [5,1])
C0392760 (UMLS CUI [5,2])
C1113679 (UMLS CUI [5,3])
C0012634 (UMLS CUI [6,1])
C0392760 (UMLS CUI [6,2])
C0525058 (UMLS CUI [6,3])
Blood test abnormal
Item
abnormal blood test
boolean
C0854146 (UMLS CUI [1])
Chest X-ray abnormal Clinical Significance
Item
clinically significant abnormality on chest x-ray (cxr)
boolean
C0436503 (UMLS CUI [1,1])
C2826293 (UMLS CUI [1,2])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial